Targeting NAT1 to improve metabolism and slow disease progression in MND (2021–2022)

Grant type:
Motor Neurone Disease Research Institute of Australia Inc Innovator Grant
Researchers:
Funded by:
Motor Neurone Disease Research Institute of Australia Inc